Thus, this positive feedback loop between NOX2-derived ROS and IFN-β, driven by LPS and thereby TLR4, has implications in the control of metabolic switching during an immune response, as well as the prevention of excessive inflammation and for cancer growth/progression. The gene discussed is IFNB1; the disease is cancer.